Salivary histatin-5 and oral fungal colonisation in HIV+ individuals
- PMID: 18983435
- DOI: 10.1111/j.1439-0507.2008.01602.x
Salivary histatin-5 and oral fungal colonisation in HIV+ individuals
Abstract
The oral cavity is a primary target for opportunistic infections, particularly oral candidiasis caused by the opportunistic pathogen Candida albicans. HIV+ individuals constitute a population highly susceptible to oral candidiasis possibly due to a change in the environment of the oral cavity as the result of salivary gland dysfunction. Histatins are a family of salivary antimicrobial peptides which under normal circumstances have a protective function on the oral mucosa. This study aimed to compare salivary histatin concentrations and oral fungal colonisation in an HIV+ and HIV- control populations. Oral samples for fungal cultures and parotid saliva were collected from all subjects. Fungal identification was determined using standard mycological procedures. In order to determine salivary histatin levels a semi-quantitative ELISA was designed using a specific polyclonal antibody and extensive statistical analysis was performed. Forty-seven percent of HIV+ and 17% of control subjects had positive fungal cultures. Mean histatin levels were 7.32 microg ml(-1) for the HIV+ group and 9.17 microg ml(-1) for control group (P = 0.003). The data from this study demonstrate that the level of fungal colonisation is significantly higher in HIV+ individuals whereas histatin-5 concentrations are significantly lower, likely contributing to the enhanced predisposition of this population to oral candidiasis.
Similar articles
-
Oral fluid proteolytic effects on histatin 5 structure and function.Arch Oral Biol. 2006 Dec;51(12):1061-70. doi: 10.1016/j.archoralbio.2006.06.005. Epub 2006 Aug 9. Arch Oral Biol. 2006. PMID: 16901460
-
Relationship between salivary histatin 5 levels and Candida CFU counts in healthy elderly.Gerodontology. 2006 Sep;23(3):164-9. doi: 10.1111/j.1741-2358.2006.00120.x. Gerodontology. 2006. PMID: 16919097
-
Histatins: antimicrobial peptides with therapeutic potential.J Pharm Pharmacol. 2004 Mar;56(3):285-9. doi: 10.1211/0022357022971. J Pharm Pharmacol. 2004. PMID: 15025852 Review.
-
Oral yeast carriage in HIV-infected and non-infected populations in Rosario, Argentina.Mycoses. 2009 Jan;52(1):53-9. doi: 10.1111/j.1439-0507.2008.01542.x. Epub 2008 May 21. Mycoses. 2009. PMID: 18498298
-
Human salivary histatins: promising anti-fungal therapeutic agents.Crit Rev Oral Biol Med. 1998;9(4):480-97. doi: 10.1177/10454411980090040601. Crit Rev Oral Biol Med. 1998. PMID: 9825223 Review.
Cited by
-
Impaired Histatin-5 Levels and Salivary Antimicrobial Activity against C. albicans in HIV Infected Individuals.J AIDS Clin Res. 2013 Mar 5;4(193):1000193. doi: 10.4172/2155-6113.1000193. J AIDS Clin Res. 2013. PMID: 23730535 Free PMC article.
-
Evidence of an increased pathogenic footprint in the lingual microbiome of untreated HIV infected patients.BMC Microbiol. 2012 Jul 28;12:153. doi: 10.1186/1471-2180-12-153. BMC Microbiol. 2012. PMID: 22838383 Free PMC article.
-
Specific metallo-protein interactions and antimicrobial activity in Histatin-5, an intrinsically disordered salivary peptide.Sci Rep. 2019 Nov 21;9(1):17303. doi: 10.1038/s41598-019-52676-7. Sci Rep. 2019. PMID: 31754129 Free PMC article.
-
Heme Peroxidases at Unperturbed and Inflamed Mucous Surfaces.Antioxidants (Basel). 2021 Nov 12;10(11):1805. doi: 10.3390/antiox10111805. Antioxidants (Basel). 2021. PMID: 34829676 Free PMC article. Review.
-
Evaluation of human body fluids for the diagnosis of fungal infections.Biomed Res Int. 2013;2013:698325. doi: 10.1155/2013/698325. Epub 2013 Aug 1. Biomed Res Int. 2013. PMID: 23984401 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical